193 related articles for article (PubMed ID: 36788737)
1. Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis.
Okamoto T; Murata Y; Hasegawa D; Yoshida M; Tanaka D; Ueda T; Hazama D; Oduori OS; Komori S; Takai T; Saito Y; Kotani T; Kosaka Y; Maniwa Y; Matozaki T
Cancer Sci; 2023 May; 114(5):1871-1881. PubMed ID: 36788737
[TBL] [Abstract][Full Text] [Related]
2. Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells.
Lim KPH; Milne P; Poidinger M; Duan K; Lin H; McGovern N; Abhyankar H; Zinn D; Burke TM; Eckstein OS; Chakraborty R; Sengal A; Scull B; Newell E; Merad M; McClain KL; Man TK; Ginhoux F; Collin M; Allen CE
Blood Adv; 2020 Jan; 4(1):87-99. PubMed ID: 31899802
[TBL] [Abstract][Full Text] [Related]
3. RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.
Hogstad B; Berres ML; Chakraborty R; Tang J; Bigenwald C; Serasinghe M; Lim KPH; Lin H; Man TK; Remark R; Baxter S; Kana V; Jordan S; Karoulia Z; Kwan WH; Leboeuf M; Brandt E; Salmon H; McClain K; Poulikakos P; Chipuk J; Mulder WJM; Allen CE; Merad M
J Exp Med; 2018 Jan; 215(1):319-336. PubMed ID: 29263218
[TBL] [Abstract][Full Text] [Related]
4. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.
Berres ML; Lim KP; Peters T; Price J; Takizawa H; Salmon H; Idoyaga J; Ruzo A; Lupo PJ; Hicks MJ; Shih A; Simko SJ; Abhyankar H; Chakraborty R; Leboeuf M; Beltrão M; Lira SA; Heym KM; Bigley V; Collin M; Manz MG; McClain K; Merad M; Allen CE
J Exp Med; 2014 Apr; 211(4):669-83. PubMed ID: 24638167
[TBL] [Abstract][Full Text] [Related]
5. CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis.
Lonardi S; Scutera S; Licini S; Lorenzi L; Cesinaro AM; Gatta LB; Castagnoli C; Bollero D; Sparti R; Tomaselli M; Medicina D; Calzetti F; Cassatella MA; Facchetti F; Musso T; Vermi W
Cancer Immunol Res; 2020 Jun; 8(6):829-841. PubMed ID: 32238382
[TBL] [Abstract][Full Text] [Related]
6. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis.
Sahm F; Capper D; Preusser M; Meyer J; Stenzinger A; Lasitschka F; Berghoff AS; Habel A; Schneider M; Kulozik A; Anagnostopoulos I; Müllauer L; Mechtersheimer G; von Deimling A
Blood; 2012 Sep; 120(12):e28-34. PubMed ID: 22859608
[TBL] [Abstract][Full Text] [Related]
7. BRAFV600E and MAP2K1 mutations in Langerhans cell histiocytosis occur predominantly in children.
Zeng K; Ohshima K; Liu Y; Zhang W; Wang L; Fan L; Li M; Li X; Wang Z; Guo S; Yan Q; Guo Y
Hematol Oncol; 2017 Dec; 35(4):845-851. PubMed ID: 27597420
[TBL] [Abstract][Full Text] [Related]
8. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.
Allen CE; Li L; Peters TL; Leung HC; Yu A; Man TK; Gurusiddappa S; Phillips MT; Hicks MJ; Gaikwad A; Merad M; McClain KL
J Immunol; 2010 Apr; 184(8):4557-67. PubMed ID: 20220088
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis.
Xiao Y; van Halteren AGS; Lei X; Borst J; Steenwijk E; de Wit T; Grabowska J; Voogd R; Kemps P; Picarsic J; van den Bos C; Borst J
Blood; 2020 Nov; 136(19):2188-2199. PubMed ID: 32750121
[TBL] [Abstract][Full Text] [Related]
10. KRAS
Kamata T; Giblett S; Pritchard C
Blood; 2017 Jul; 130(4):514-526. PubMed ID: 28550040
[TBL] [Abstract][Full Text] [Related]
11. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells.
Hutter C; Kauer M; Simonitsch-Klupp I; Jug G; Schwentner R; Leitner J; Bock P; Steinberger P; Bauer W; Carlesso N; Minkov M; Gadner H; Stingl G; Kovar H; Kriehuber E
Blood; 2012 Dec; 120(26):5199-208. PubMed ID: 23074278
[TBL] [Abstract][Full Text] [Related]
12. CD207
Carrera Silva EA; Nowak W; Tessone L; Olexen CM; Ortiz Wilczyñski JM; Estecho IG; Elena G; Errasti AE; Rosso DA
Blood; 2017 Oct; 130(17):1898-1902. PubMed ID: 28847997
[TBL] [Abstract][Full Text] [Related]
13. BRAF-V600E utilizes posttranscriptional mechanisms to amplify LPS-induced TNFα production in dendritic cells in a mouse model of Langerhans cell histiocytosis.
Minichino D; Lv K; Chu N; Tong W; Behrens EM
J Leukoc Biol; 2022 Nov; 112(5):1089-1104. PubMed ID: 35648675
[TBL] [Abstract][Full Text] [Related]
14. Increased AXL
Olexen CM; Risnik D; Lava MC; Dalla Vecchia GL; Rosso DA; Errasti AE; Carrera Silva EA
Clin Immunol; 2024 Jun; 263():110203. PubMed ID: 38575046
[TBL] [Abstract][Full Text] [Related]
15. Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.
Kemps PG; Zondag TCE; Arnardóttir HB; Solleveld-Westerink N; Borst J; Steenwijk EC; van Egmond D; Swennenhuis JF; Stelloo E; Trambusti I; Verdijk RM; van Noesel CJM; Cleven AHG; Scheijde-Vermeulen MA; Koudijs MJ; Krsková L; Hawkins C; Egeler RM; Brok J; von Bahr Greenwood T; Svojgr K; Beishuizen A; van Laar JAM; Pötschger U; Hutter C; Sieni E; Minkov M; Abla O; van Wezel T; van den Bos C; van Halteren AGS
Blood Adv; 2023 Feb; 7(4):664-679. PubMed ID: 36083130
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis.
Paredes SEY; Almeida LY; Trevisan GL; Polanco XBJ; Silveira HA; Vilela Silva E; Segato RAB; da Silva LAB; Chahud F; León JE
Scand J Immunol; 2020 Dec; 92(6):e12950. PubMed ID: 32738155
[TBL] [Abstract][Full Text] [Related]
17. Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH.
Sengal A; Velazquez J; Hahne M; Burke TM; Abhyankar H; Reyes R; Olea W; Scull B; Eckstein OS; Bigenwald C; Bollard CM; Yu W; Merad M; McClain KL; Allen CE; Chakraborty R
Blood; 2021 Apr; 137(13):1777-1791. PubMed ID: 33075814
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell SIRPα regulates homeostasis of dendritic cells in lymphoid organs.
Washio K; Kotani T; Saito Y; Respatika D; Murata Y; Kaneko Y; Okazawa H; Ohnishi H; Fukunaga A; Nishigori C; Matozaki T
Genes Cells; 2015 Jun; 20(6):451-63. PubMed ID: 25818708
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the BRAFV600E mutation in 19 cases of Langerhans cell histiocytosis in Japan.
Sasaki Y; Guo Y; Arakawa F; Miyoshi H; Yoshida N; Koga Y; Nakashima K; Kurita D; Niino D; Seto M; Ohshima K
Hematol Oncol; 2017 Sep; 35(3):329-334. PubMed ID: 27041734
[TBL] [Abstract][Full Text] [Related]
20. Monitoring Circulating CD207
Olexen CM; Rosso DA; Nowak W; Fortunati D; Errasti AE; Carrera Silva EA
J Immunol; 2022 Jul; 209(2):270-279. PubMed ID: 35768149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]